Piper Sandler analyst Crispin Love sets a price target of $7.50 for NYSE:TPVG, indicating a potential increase of 15.74%.
TPVG reported a quarterly EPS of $0.35, slightly above the Zacks Consensus Estimate of $0.34.
Despite surpassing revenue estimates with $26.52 million, TPVG’s revenue has decreased from the previous year’s $35.74 million.
TriplePoint Venture Growth (NYSE:TPVG) is a business development company that provides debt financing to venture capital-backed companies. It focuses on growth-stage businesses in the technology, life sciences, and other high-growth industries. TPVG competes with other venture capital firms and financial institutions that offer similar financing solutions.
On November 7, 2024, analyst Crispin Love from Piper Sandler set a price target of $7.50 for TPVG. At that time, the stock was priced at $6.48, suggesting a potential increase of 15.74%. This optimistic outlook comes despite TPVG’s recent earnings report, which showed a quarterly earnings per share (EPS) of $0.35, slightly above the Zacks Consensus Estimate of $0.34.
However, TPVG’s recent earnings of $0.35 per share mark a decline from the $0.54 per share reported a year ago. This represents a positive surprise of 2.94% compared to expectations. In the previous quarter, TPVG faced a negative surprise of 23.26%, earning only $0.33 per share against an expected $0.43. Over the past four quarters, TPVG has exceeded consensus EPS estimates only once.
TPVG’s revenue for the quarter ending September 2024 was $26.52 million, surpassing the Zacks Consensus Estimate by 3.39%. Despite this, it is a decrease from the $35.74 million reported a year earlier. The stock is currently priced at $7.61, reflecting an 11.71% increase, with a trading range today between $7.01 and $7.65. The company’s market capitalization is approximately $303.8 million, with a trading volume of 588,741 shares.
